세계의 요실금 장치 시장 : 제품별, 요실금 유형별, 환자 유형별, 최종사용자별, 지역별 - 예측(-2030년)

Urinary Incontinence Devices Market by Product (Urinary Catheters (Indwelling Catheters, Intermittent Catheters), Artificial Urinary Sphincters), Incontinence Type (Stress), Patient Type (Male, Female), End User (Hospitals) - Global Forecast to 2030

US $ 4,950 ￦ 7,024,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,437,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,565,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 요실금 장치 시장 규모는 2024년 42억 2,000만 달러에서 2030년에는 79억 7,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 11.2%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

조사 범위
조사 대상 연도	2023-2030년
기준 연도	2023년
예측 기간	2023-2030년
검토 단위	금액(10억 달러)
부문	제품별, 요실금 유형별, 환자 유형별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

이는 개인 위생에 대한 관심 증가와 재택치료 솔루션의 발전으로 인한 것입니다. 또한 급속한 도시화와 가처분 소득 증가로 인해 요실금 장치에 대한 수요가 증가하고 있습니다. 그러나 카테터와 같은 요실금 장치 사용으로 인한 부작용과 합병증의 가능성이 시장의 주요 억제요인으로 작용하고 있습니다. 또한, 요실금 치료를 위한 대체 치료 옵션의 사용은 시장 성장에 큰 과제입니다. 그러나 2024-2030년의 예측 기간 동안에는 시장 성장을 위한 환경이 조성되고 있습니다.

요실금 유형별로 요실금 장치 시장은 복압성 요실금, 절박성 요실금, 혼합성 요실금, 복압성 요실금, 복압성 요실금, 기능성 요실금으로 나뉩니다. 이 중 2023년 요실금 장치 시장에서 복압성 요실금 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 복압성 요실금 부문의 성장을 가속하는 요인으로는 고령화 인구 증가, 특히 폐경 후 여성의 골반저 기능 장애의 유병률 증가를 들 수 있습니다. 복압성 요실금 유병률 증가는 요도 카테터, 질 및 요도 슬링, 인공 요도 괄약근, 전기 자극 장치와 같은 요실금 장치에 대한 수요를 촉진하고 있습니다. 미국 국립생물공학정보센터(NCBI)에 따르면 복압성 요실금(SUI)이 가장 많이 보고되고 있으며, 전체 요실금 환자의 37.5%를 차지합니다. 이러한 높은 보급률은 요실금 장치에 대한 수요가 증가하고 있음을 보여줍니다.

환자 유형별로 요실금 장치 시장은 남성 환자와 여성 환자로 구분됩니다. 여성 환자는 요실금 장치 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 여성은 임신, 출산, 폐경 등의 요인으로 인해 남성보다 요실금이 발생하기 쉽습니다. 이러한 사건마다 여성은 방광 조절 문제에 직면할 수 있습니다. 임신은 요실금과 방광 조절 문제의 단기적인 원인이 될 수 있습니다. 출산은 골반저근육에 부담을 주기 때문에 일부 여성들은 출산 후 요실금을 경험하기도 합니다. 폐경기에는 에스트로겐의 감소가 방광 조절에 영향을 미칠 수 있습니다. 그러나 요실금 유병률은 연령에 따라 증가하는 것으로 알려져 있으며, 65세 이상 여성의 최대 75%가 소변 누출과 같은 요실금 에피소드를 보고하고 있어 이 부문의 요실금 장치에 대한 시장 수요는 더욱 증가할 것으로 예상됩니다.

세계의 요실금 기기 시장을 조사했으며, 제품별/요실금 유형별/환자 유형별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 상황
• 무역 분석
• 특허 분석
• 2025-2026년 주요 컨퍼런스 및 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 기술 분석
• 투자와 자금조달 시나리오
• AI/생성형 AI가 요실금 장치 시장에 미치는 영향

제6장 요실금 장치 시장(제품별)

• 서론
• 요도 카테터
• 질 및 요도 슬링
• 전기 자극 장치
• 인공 요도 괄약근
• 기타

제7장 요실금 장치 시장(요실금 유형별)

• 서론
• 복압성 요실금
• 절박성 요실금
• 혼합성 요실금
• 일류성 요실금
• 기능성 요실금

제8장 요실금 치료 기기 시장(환자 유형별)

• 서론
• 여성 환자
• 남성 환자

제9장 요실금 장치 시장(최종사용자별)

• 서론
• 병원
• 진료소
• 기타

제10장 요실금 장치 시장(지역별)

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 중국
  • 일본
  • 인도
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 시장 성장을 지지하는 헬스케어 인프라 개선
  • 중동 및 아프리카의 거시경제 전망

제11장 경쟁 구도

• 서론
• 주요 시장 진출기업의 전략/강점
• 매출 분석, 2019년-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 시장 진출기업
  • COLOPLAST CORP.
  • B. BRAUN SE
  • JOHNSON & JOHNSON SERVICES, INC.
  • CONVATEC INC.
  • BOSTON SCIENTIFIC CORPORATION
  • MEDTRONIC
  • TELEFLEX INCORPORATED
  • BECTON, DICKINSON AND COMPANY(BD)
  • CARDINAL HEALTH
  • HOLLISTER INCORPORATED
  • COOK GROUP
  • LABORIE
• 기타 기업
  • WELLSPECT HEALTHCARE
  • CALDERA MEDICAL
  • DYNAREX CORPORATION
  • ADVACARE PHARMA
  • MRK HEALTHCARE PVT. LTD.
  • ADVIN HEALTH CARE
  • CLINIMED LIMITED
  • STERIMED GROUP
  • KIMBERLY-CLARK CORPORATION(KCWW)
  • INCONTROL MEDICAL
  • ZEPHYR SURGICAL IMPLANTS
  • FLEXICARE(GROUP) LIMITED
  • STRYKER

제13장 부록

LSH

영문 목차

영문목차

The global Urinary incontinence devices market is projected to reach USD 7.97 billion by 2030 from USD 4.22 billion in 2024, at a CAGR of 11.2% during the forecast period.

Scope of the Report
Years Considered for the Study	2023-2030
Base Year	2023
Forecast Period	2023-2030
Units Considered	Value (USD billion)
Segments	Product, Incontinence type, Patient type, End User, and Region
Regions covered	North America, Europe, APAC, LATAM, MEA

This is due to growing attention to personal hygiene and advancements in home healthcare solutions. Additionally, rapid urbanization and rising disposable income, consequently increasing the demand for the urinary incontinence devices. However, the potential side-effects & complications by using urinary incontinence devices such as catheters are the major restraint to the market. Additionally, the use of alternative treatment options to treat urinary icnotinence is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.

"The stress incontinence segment of urinary incontinence devices market by incontinence type to hold largest position forecast period."

Based on the incontinence type, the urinary incontinence devices market is divided into stress incontinence, urge incontinence, mixed incontinence, overflow incontinence, and functional incontinence. Among these, in 2023 stress incontinence segment account for the largest market share of XX% in urinary incontinence devices market. Factors driving the growth of stress incontinence segment include rising aging population, which increases the prevalence of pelvic floor dysfunction, particularly among postmenopausal women. The growing prevalence of stress incontinence is driving demand for urinary incontinence devices, including urinary catheters, vaginal & urethral slings, artificial urinary sphincters, electrical stimulation devices are among the others. According to National Center for Biotechnology Information (NCBI), stress urinary incontinence (SUI) is the most reported type, accounting for 37.5% of cases. This significant prevalence highlights the growing demand for urinary incontinence devices.

"The female patients segment accounts for the largest market share in urinary incontinence devices market."

Based on patient type, the urinary incontinence devices market is segmented into male patients and female patients. The female patients segment accounts for the largest market share in urinary incontinence devices market. Women are more prone to incontinence than men, owing to factors such as pregnancy, childbirth, and menopause. During each of these events, women can face bladder control issues. Pregnancy can be a short-term cause of incontinence and bladder control issues. Some women experience incontinence after delivery because of the strain childbirth takes on the pelvic floor muscles. During menopause, the decreasing level of estrogen affects bladder control. However, the prevalence of incontinence is known to increase with age, with up to 75% of women above 65 years reporting an episode of incontinence such as urine leakage, further strengthens market demand for urinary incontinence devices among this segment.

"North America accounted for the second largest share of the urinary incontinence devices market by region."

The global urinary incontinence devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Urinary incontinence devices market in North America is the second-largest regional market. This is due to the growing geriatric population along with rising prevalence of urinary incontinence as well as rapid advancement of healthcare infrastructure. The industry has long been established in the area, with high early-stage support and adoption by clinicians for research and emerging technologies. It is characterized by significant market penetration of urinary incontinence devices among key end users. However, the population of North America was approximately 375 million in 2023, with 66.8 million people aged 65 and above, a demographic that is particularly at risk of urinary incontinence. Such factors create a favorable environment for the growth of the urinary incontinence devices market in this region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
• By Designation: C-level-27%, Director-level-18% and Others-55%
• By Region: Europe-35%, North America-30%, Asia Pacific-22%, Latin America- 10%, and Middle east and Africa - 3%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the urinary incontinence devices market are Coloplast Corp (Denmark), B. Braun SE (Germany), Johnson & Johnson Services, Inc. (US), Convatec Inc. (UK), Boston Scientific Corporation (US), Hollister Incorporated (US), Becton, Dickinson and Company (BD) (US), Cook Group (US), Cardinal Health (US), Laborie (US), Medtronic (Ireland), and Teleflex Incorporated (US).

Research Coverage

This report studies the urinary incontinence devices market based on product, incontinence type, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (Rising prevalence of urinary incontinence, Expanding geriatric population, Growing attention to personal hygiene, and Advancements in home healthcare solutions), restraints (Social stigma associate with incontinence care products, Environmental concerns related to disposal of urinary incontinence products, and Potential side-effects & complications), Challenge (Use of alternative treatment options), opportunity (Technological advancements in urinary incontinence devices and Rapid urbanization and rising disposable income)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the urinary incontinence devices market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches & product approvals in the urinary incontinence devices market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the urinary incontinence devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.1.1 Presentations of companies and primary interviews
      • 2.2.1.1.2 Primary interviews
      • 2.2.1.1.3 US-based approach
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 ASSUMPTIONS
  • 2.5.1 STUDY ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 URINARY INCONTINENCE DEVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT & COUNTRY (2023)
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 REGIONAL MIX: URINARY INCONTINENCE DEVICES MARKET, 2024 VS. 2030
• 4.5 URINARY INCONTINENCE DEVICES MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of urinary incontinence
    • 5.2.1.2 Expanding geriatric population
    • 5.2.1.3 Growing attention to personal hygiene
    • 5.2.1.4 Advancements in home healthcare solutions
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Social stigma associated with incontinence care products
    • 5.2.2.2 Environmental concerns related to disposal of urinary incontinence products
    • 5.2.2.3 Potential side-effects & complications
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Technological advancements in urinary incontinence devices
    • 5.2.3.2 Rapid urbanization and rising disposable income
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Use of alternative treatment options
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9.2 REGULATORY FRAMEWORK
    • 5.9.2.1 North America
      • 5.9.2.1.1 US
      • 5.9.2.1.2 Canada
    • 5.9.2.2 Europe
    • 5.9.2.3 Asia Pacific
      • 5.9.2.3.1 China
      • 5.9.2.3.2 Japan
      • 5.9.2.3.3 India
    • 5.9.2.4 Latin America
      • 5.9.2.4.1 Brazil
      • 5.9.2.4.2 Mexico
    • 5.9.2.5 Middle East
    • 5.9.2.6 Africa
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 901839
  • 5.10.2 EXPORT DATA FOR HS CODE 901839
• 5.11 PATENT ANALYSIS
  • 5.11.1 LIST OF MAJOR PATENTS
• 5.12 KEY CONFERENCES & EVENTS, 2025-2026
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 TECHNOLOGY ANALYSIS
  • 5.14.1 KEY TECHNOLOGIES
    • 5.14.1.1 Surgical & implantable devices
  • 5.14.2 COMPLEMENTARY TECHNOLOGIES
    • 5.14.2.1 Electrical stimulation devices
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF AI/GEN AI ON URINARY INCONTINENCE DEVICES MARKET
  • 5.16.1 AI USE CASES

6 URINARY INCONTINENCE DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 URINARY CATHETERS
  • 6.2.1 INTERMITTENT CATHETERS
    • 6.2.1.1 Reduced risk of infections to boost market
  • 6.2.2 INDWELLING CATHETERS
    • 6.2.2.1 Rising usage by critically ill patients to drive demand
  • 6.2.3 EXTERNAL CATHETERS
    • 6.2.3.1 Ease of use to boost market growth
• 6.3 VAGINAL & URETHRAL SLINGS
  • 6.3.1 RISING PREVALENCE OF STRESS INCONTINENCE TO DRIVE GROWTH
• 6.4 ELECTRICAL STIMULATION DEVICES
  • 6.4.1 GROWING PREFERENCE FOR ELECTRICAL STIMULATION DEVICES FOR TREATMENT OF OAB TO DRIVE GROWTH
• 6.5 ARTIFICIAL URINARY SPHINCTERS
  • 6.5.1 REDUCED RISK OF INFECTIONS ASSOCIATED WITH ARTIFICIAL URINARY SPHINCTERS TO DRIVE ADOPTION
• 6.6 OTHER URINARY INCONTINENCE DEVICES

7 URINARY INCONTINENCE DEVICES MARKET, BY INCONTINENCE TYPE

• 7.1 INTRODUCTION
• 7.2 STRESS INCONTINENCE
  • 7.2.1 GROWING PREVALENCE OF STRESS INCONTINENCE TO DRIVE MARKET GROWTH
• 7.3 URGE INCONTINENCE
  • 7.3.1 CONTINUOUS INNOVATIONS TO SUSTAIN MARKET GROWTH
• 7.4 MIXED INCONTINENCE
  • 7.4.1 GROWING AWARENESS AMONG BOTH PATIENTS AND HEALTHCARE PROVIDERS TO BOOST MARKET GROWTH
• 7.5 OVERFLOW INCONTINENCE
  • 7.5.1 AGING POPULATION AND ASSOCIATED UROLOGICAL CONDITIONS TO DRIVE MARKET DEMAND
• 7.6 FUNCTIONAL INCONTINENCE
  • 7.6.1 MOBILITY DISORDERS TO SUSTAIN MARKET GROWTH

8 URINARY INCONTINENCE DEVICES MARKET, BY PATIENT TYPE

• 8.1 INTRODUCTION
• 8.2 FEMALE PATIENTS
  • 8.2.1 HIGHER RATE OF URINARY INCONTINENCE IN FEMALES TO DRIVE MARKET
• 8.3 MALE PATIENTS
  • 8.3.1 RISING PREVALENCE OF BPH TO PROPEL MARKET GROWTH

9 URINARY INCONTINENCE DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 LARGE VOLUME OF SURGICAL PROCEDURES TO DRIVE GROWTH
• 9.3 PHYSICIANS' OFFICES
  • 9.3.1 EXPERTISE OF PROFESSIONALS IN TREATMENT OF URINARY INCONTINENCE TO PROPEL GROWTH
• 9.4 OTHER END USERS

10 URINARY INCONTINENCE DEVICES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Favorable healthcare initiatives for prevention of UI to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing geriatric population to drive market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Rising healthcare expenditure to propel market
  • 10.3.3 UK
    • 10.3.3.1 Rising prevalence of chronic diseases to support market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Large target population to boost demand
  • 10.3.5 ITALY
    • 10.3.5.1 Rising geriatric population and subsequent rise in UI to drive market
  • 10.3.6 SPAIN
    • 10.3.6.1 Uptake of advanced technologies for UI treatment to support market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Growing focus on preventive care due to large target patient pool to boost demand
  • 10.4.3 JAPAN
    • 10.4.3.1 Presence of established healthcare system and favorable reimbursements to drive market
  • 10.4.4 INDIA
    • 10.4.4.1 Rising cases of urinary incontinence and increasing healthcare investments to propel market
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Favorable reimbursement scenario for medical device manufacturers to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Rising demand for advanced UI products to drive market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN URINARY INCONTINENCE DEVICES MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Patient type footprint
    • 11.5.5.5 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startup/SME players
    • 11.6.5.2 Competitive benchmarking of key emerging players/startups
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS
  • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 COLOPLAST CORP.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 B. BRAUN SE
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Key strengths
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Key strengths
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 CONVATEC INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 BOSTON SCIENTIFIC CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 MEDTRONIC
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product approvals
  • 12.1.7 TELEFLEX INCORPORATED
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 BECTON, DICKINSON AND COMPANY (BD)
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 CARDINAL HEALTH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 HOLLISTER INCORPORATED
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches
  • 12.1.11 COOK GROUP
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 LABORIE
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Other developments
• 12.2 OTHER PLAYERS
  • 12.2.1 WELLSPECT HEALTHCARE
  • 12.2.2 CALDERA MEDICAL
  • 12.2.3 DYNAREX CORPORATION
  • 12.2.4 ADVACARE PHARMA
  • 12.2.5 MRK HEALTHCARE PVT. LTD.
  • 12.2.6 ADVIN HEALTH CARE
  • 12.2.7 CLINIMED LIMITED
  • 12.2.8 STERIMED GROUP
  • 12.2.9 KIMBERLY-CLARK CORPORATION (KCWW)
  • 12.2.10 INCONTROL MEDICAL
  • 12.2.11 ZEPHYR SURGICAL IMPLANTS
  • 12.2.12 FLEXICARE (GROUP) LIMITED
  • 12.2.13 STRYKER

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료